ArticleThe international journal of cardiovascular imaging2026
Ventilation-perfusion (V/Q) scans: trends from medicare part B (2013-2023).
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ventilation-Perfusion (V/Q) scan has been established as a nuclear imaging modality for diagnosis of pulmonary embolism (PE), especially in patients with contraindications computed tomography pulmonary angiography (CTPA). However, its use in United States is declining. We analyzed national Medicare data (2013-2023) to assess V/Q and Q scan utilization and physician procedure volumes. Our analysis shows that annual V/Q scans have been declining over the period from 2013 to 2023, with a marked drop occurring between 2019 and 2020 (COVID-19 era). Most of the V/Q scans have been read by low volume readers (< 11/ year). Low-volume readers percentage increased from 20.3% in 2013 to 43.4% in 2023. These trends may impact diagnostic quality and highlight the need to reassess training, competency, and access to V/Q imaging for patients contraindicated for CTPA.
Indexed as
Identifiers
42295557What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.